| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 08/06/2008 | CN101235012A Method for preparing 6-methoxy-1,2,3,9-4H-carbazol-4-one |
| 08/06/2008 | CN101235011A N-amino-1,2-cyclopentanediformylimine and preparation method thereof |
| 08/06/2008 | CN101235010A Method for preparing 4,4'-di(4-carboxyphthalimido)-4''-hydroxytriphenylmethane |
| 08/06/2008 | CN101235009A Method for preparing 2,2-di[3-(4-chlorophthalimido)-4-hydroxyphenyl]hexafluoropropane |
| 08/06/2008 | CN100408582C Homocamptoth-ecine compounds, their preparation process and use |
| 08/06/2008 | CN100408552C Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production |
| 08/06/2008 | CN100408093C Use of inhibitor of angiotonin converzyme in preparing pharmaceutical formulations for prevention of stroke, diabetes and/or congestive heart failure |
| 08/05/2008 | US7408076 2-Bromoanaline and 2-chloroaniline compounds |
| 08/05/2008 | US7407988 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 08/05/2008 | US7407983 Indole derivatives substituted with long-chain alcohols and medicaments containing them |
| 08/05/2008 | US7407982 Polyoxyethylene glycol conjugates mean the drug is eliminated almost completely through the kidneys; bioavailability; anticoagulants |
| 08/05/2008 | CA2334577C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 07/31/2008 | WO2008090819A1 Process for production of bicyclic proline compound |
| 07/31/2008 | WO2008089636A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv |
| 07/31/2008 | WO2008063867A3 Tetrahydrocyclopenta[b] indole compounds as androgen receptor modulators |
| 07/31/2008 | WO2008057775A3 Heterocyclic amide compounds useful as kinase inhibitors |
| 07/31/2008 | WO2007135380A3 Antiparasitic compounds and compositions |
| 07/31/2008 | WO2007109178A3 Indole derivatives as inhibitors of histone deacetylase |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182873 Process for the manufacture of hmg-coa reductase inhibitors |
| 07/31/2008 | DE102007002714A1 Neue Materialien für organische Elektrolumineszenzvorrichtungen New materials for organic electroluminescent |
| 07/31/2008 | CA2673164A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv |
| 07/30/2008 | EP1950200A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| 07/30/2008 | EP1950195A1 Aromatic amine derivative and organic electroluminescent device using same |
| 07/30/2008 | EP1948605A2 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 07/30/2008 | EP1948604A1 Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors |
| 07/30/2008 | EP1948603A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 07/30/2008 | EP1948602A2 Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors |
| 07/30/2008 | EP1948601A1 Fab i inhibitor and process for preparing same |
| 07/30/2008 | EP1948600A2 Liver targeted conjugates |
| 07/30/2008 | EP1948224A1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension |
| 07/30/2008 | EP1948166A1 Carbazole derivatives as functional 5-ht6 ligands |
| 07/30/2008 | EP1592684B1 Malonamide derivatives as gamma-secretase inhibitors |
| 07/30/2008 | EP1542973B1 2,4-substituted indoles and their use as 5-ht6 modulators |
| 07/30/2008 | CN101233115A Indole and benzimidazole derivatives |
| 07/30/2008 | CN101233105A Tryptophan derivative and use thereof |
| 07/30/2008 | CN101232901A Joint use of sulfonamide based compound with angiogenesis inhibitor |
| 07/30/2008 | CN101231243A Agent and method for testing reticulocyte |
| 07/30/2008 | CN101230059A Bicycle aza alkyl derivative, preparation method and use in medicine thereof |
| 07/30/2008 | CN101230058A Bicycle aza alkyl derivative, preparation method and use in medicine thereof |
| 07/30/2008 | CN101230036A Method for preparing heterocyclic aryl-aryl biphenyl compounds |
| 07/30/2008 | CN101230033A New azabicycloalkane derivatives, preparing method and medicament combination containing the same |
| 07/30/2008 | CN101230032A Method for preparing 2,2-bi[3-(4-chlorinephthalimide)-4-hydroxyphenyl] propane |
| 07/30/2008 | CN101230031A Method for preparing 2,2-bi[3-(4-carboxylphthalimide)-4-hydroxyphenyl] hexafluoropropane |
| 07/30/2008 | CN101230030A Method for preparing 2,2-bi[3-(4-carboxylphthalimide)-4-hydroxyphenyl] propane |
| 07/30/2008 | CN101229988A Method for refining high-purity anthracene and carbazole from crude anthracene |
| 07/30/2008 | CN100406460C Novel derivative of camptothecine, preparing method and use |
| 07/30/2008 | CN100406459C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 07/30/2008 | CN100406440C Crystal of sulfonamide-containing indole compound and process for producing the same |
| 07/30/2008 | CN100406013C Camptothecin derivatives |
| 07/30/2008 | CN100406009C Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 07/30/2008 | CN100406007C Asthma and allergic inflammation modulators |
| 07/29/2008 | US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405300 Central nervous system disorders; cardiovascular disorders; antiischemic agents; strokes; antiarthritic agents; anticancer agents; muscular disorders |
| 07/29/2008 | US7405237 Isoindoline compounds and methods of their use |
| 07/29/2008 | US7405236 e.g. {6-[5-(4-trifluoromethoxy-phenyl)-pent-4-ynyloxy]-indol-1-yl}-acetic acid; peroxisome proliferator activated receptor PPAR delta or PPAR alpha agonist; antidiabetic, antiinflammatory agent, cardiovascular disorders; non-insulin dependent diabetes, insulin resistance, atherosclerosis |
| 07/29/2008 | US7405218 Isothiazole derivatives useful as anticancer agents |
| 07/29/2008 | US7405070 Reacting with methanol and thionyl chloride using Savinase, Alcalase, Protease and Acylase; superior optical purity and yield |
| 07/29/2008 | US7405065 Such as 1S,4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene via N-acetylamino-alcohol hydrolase isolated from Rhodococcus, Gordona, Arthrobacter, Alcaligenes, Agrobacterium/Rhizobium, Bacillus, Pseudomonas or Alcaligenes/Bordetella |
| 07/29/2008 | CA2405486C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 07/29/2008 | CA2359592C Pharmaceutical compositions for alleviating discomfort |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2205811C Multifunctional cyanate ester and epoxy blends |
| 07/24/2008 | WO2008089453A2 Inhibitors of d-amino acid oxidase |
| 07/24/2008 | WO2008089015A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008087278A2 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors |
| 07/24/2008 | WO2008060190A3 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 07/24/2008 | WO2008055068A8 Inhibitors of histone deacetylase |
| 07/24/2008 | WO2008054690A3 Polymorphs of a hydroisoindoline tachykinin receptor antagonist |
| 07/24/2008 | WO2007134236A3 Imaging agents and methods |
| 07/24/2008 | US20080177085 Process for the Synthesis of a CPLA2 Inhibitor |
| 07/24/2008 | US20080177084 Iridium complex, carbazole derivatives and copolymer having the same |
| 07/24/2008 | US20080177073 Imidation of derivatives of anthracene-2,3:6,7-dianhydride, napthalene-1,4:5,8-dianhydride, or perylene-3,4:9,10-anhydride with primary amine to perylene-bis(dicarboximide)s, naphthalene-bis(dicarboximide)s, and anthracene-bis(dicarboximide)s and/or coronene-bis(dicarboximide)s; electronics, composites |
| 07/24/2008 | US20080177027 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses |
| 07/24/2008 | US20080176922 Uses of 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssris |
| 07/24/2008 | US20080176917 Schizophrenia; bioavailability, solubility, brain penetrancy; in vivo half life; synthesis; such as 3-[3-({4-methyl-5-[4-(pentafluoro-6-sulfanyl)phenyl]-4H-1,2,4-triazol-3-yl}thio)propyl]-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane |
| 07/24/2008 | US20080176868 Preparation and use of compounds as protease inhibitors |
| 07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
| 07/24/2008 | US20080176841 (amidomethyl-amido)-(carboxy/amido)epoxide derivatives; cathepsin inhibitor; antiinflammatory, anticarcinogenic, antidiabeticagent, antiallergen, autoimmune and neurodegenerative disorders |
| 07/24/2008 | CA2676432A1 Inhibitors of d-amino acid oxidase |
| 07/24/2008 | CA2674946A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/23/2008 | EP1947085A1 Substituted indole sulfonamide compounds, their preparation and use as medicaments |
| 07/23/2008 | EP1945705A1 Photolatent systems |
| 07/23/2008 | EP1945612A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 07/23/2008 | EP1945611A1 N- (hetero) aryl indole derivatives as pesticides |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1389223B1 Method for producing polyisocyanates |
| 07/23/2008 | EP0957914B2 Formulation of 5-ht agonists |
| 07/23/2008 | CN101228160A Azaindoles useful as inhibitors of protein kinases |
| 07/23/2008 | CN101228126A Process for the preparation of crystalline perindopril |
| 07/23/2008 | CN101228125A Cathepsin K inhibitors |
| 07/23/2008 | CN101228120A HIV reverse transcriptase inhibitors |
| 07/23/2008 | CN101228118A Process for the synthesis of sulfonyl halides and sulfonamides from sulfonic acid salts |
| 07/23/2008 | CN101227902A New crystalline form of perindopril erbumine |
| 07/23/2008 | CN101225070A Antineoplastic medicament |